semaglutide and cardiovascular outcomes in obesity without diabetes journal club New Science Suggests Improves CV Beyond Weight Loss #VisualAbstract: Semaglutide and Cardiovascular Outcomes

Vitamin K Dependent Antagonists Vitamin K antagonists (VKAs) are a class of anticoagulant medications used to prevent and treat blood clots

Other medications that cause drowsiness, such as beta-blockers to control blood pressure, are often used by people with type 2 diabetes

It is important to understand how the immune system works and the inflammatory response that occurs when a foreign pathogen enters the body

Conclusion Semaglutide and tamoxifen are two different medicines that can impact weight and overall health in specific ways

Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients